Management of Acute Psychosis in Patients on Long-Acting Antipsychotics

Clinical Practice Guidelines

• The American College of Physicians and other guideline societies support using atypical antipsychotics for acute psychosis management, with risperidone specifically recommended at 0.5-1 mg BID for acute agitation and psychotic symptoms 1, 2, 3
• The proposed dose of 1mg BID falls within recommended starting ranges for acute psychosis, with an initial target dose of 2 mg/day for adults 4, 5

Dosing Strategy

• The British Journal of Psychiatry recommends starting with risperidone 1mg BID, which provides a total daily dose of 2mg, the recommended initial target dose for acute psychosis 4, 5
• The Annals of Oncology suggests monitoring for excessive sedation from combined antipsychotic effects, particularly in the first 48-72 hours 2

Critical Safety Considerations

• The Annals of Emergency Medicine recommends checking QTc interval if feasible, as both aripiprazole and risperidone can prolong QTc, though clinically significant prolongation is rare 7

Alternative Considerations

• The Journal of the National Comprehensive Cancer Network recommends considering haloperidol 0.5-2mg every 1 hour PRN for rapid control of severe agitation 1, 3
• The British Journal of Psychiatry suggests maintaining continuity of care with the same treating clinicians for at least 18 months to optimize outcomes 4, 6